Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase Cα regulates eIF4G1 binding to Mnk1

Molecular and Cellular Biology

Volumn 31, Issue 14, 2011, Pages 2947-2959

  Dobrikov, Mikhail ^a   Dobrikova, Elena ^a   Shveygert, Mayya ^a   Gromeier, Matthias ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTIC TRANSLATION INITIATION FACTOR 4G1; INITIATION FACTOR 4E; INITIATION FACTOR 4G; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE SIGNAL INTEGRATING KINASE; PROTEIN KINASE C ALPHA; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; EUKARYOTIC INITIATION FACTOR-4G; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PHORBOL ESTERS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; PROTEIN-SERINE-THREONINE KINASES; RAS PROTEINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 79960383717     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05589-11     Document Type: Article

References (44)

1. Bain, J., et al. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408:297-315.
2. Bellsolell, L., P. F. Cho-Park, F. Poulin, N. Sonenberg, and S. K. Burley. 2006. Two structurally atypical HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1. Structure 14:913-923.
3. Brunn, G. J., et al. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99-101.
4. Byrd, M. P., M. Zamora, and R. E. Lloyd. 2002. Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons. Mol. Cell. Biol. 22:4499-4511.
5. DeGracia, D. J., J. A. Rafols, S. J. Morley, and F. Kayali. 2006. Immunohistochemical mapping of total and phosphorylated eukaryotic initiation factor 4G in rat hippocampus following global brain ischemia and reperfusion. Neuroscience 139:1235-1248.
6. Dephoure, N., et al. 2008. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105:10762-10767.
7. Fujita, Y., et al. 2009. Domain-dependent interaction of eukaryotic initiation factor eIF4A for binding to middle and C-terminal domains of eIF4G. J. Biochem. 146:359-368.
8. Fukunaga, R., and T. Hunter. 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1921-1933.
9. Furic, L., et al. 2010. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl. Acad. Sci. U. S. A. 107:14134-14139.
10. Gauci, S., et al. 2009. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. 81:4493-4501.
11. Geiges, D., et al. 1997. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumorpromoting agents. Biochem. Pharmacol. 53:865-875.
12. Gingras, A. C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913-963.
13. Haghighat, A., S. Mader, A. Pause, and N. Sonenberg. 1995. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14:5701-5709.
14. Harris, T. E., et al. 2006. mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J. 25:1659-1668.
15. Herbert, T. P., G. R. Kilhams, I. H. Batty, and C. G. Proud. 2000. Distinct signalling pathways mediate insulin and phorbol ester-stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem. 275:11249-11256.
16. Hershey, J. W., and W. C. Merrick. 2000. Pathway and mechanism of initiation of protein synthesis, p. 637-654. In N. Sonenberg, J. W. Hershey, and M. B. Mathews (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Huang, F. L., Y. Yoshida, J. R. Cunha-Melo, M. A. Beaven, and K. P. Huang. 1989. Differential down-regulation of protein kinase C isozymes. J. Biol. Chem. 264:4238-4243.
18. Kaiser, C., et al. 2008. Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo. RNA. 14:2170-2182.
19. Mackay, H. J., and C. J. Twelves. 2007. Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer. 7:554-562.
20. Marcotrigiano, J., A. C. Gingras, N. Sonenberg, and S. K. Burley. 1999. Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol. Cell 3:707-716.
21. Marcotrigiano, J., et al. 2001. A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol. Cell 7:193-203.
22. Marintchev, A., et al. 2009. Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation. Cell 136:447-460.
23. Marintchev, A., and G. Wagner. 2005. eIF4G and CBP80 share a common origin and similar domain organization: implications for the structure and function of eIF4G. Biochemistry 44:12265-12272.
24. Morino, S., H. Imataka, Y. V. Svitkin, T. V. Pestova, and N. Sonenberg. 2000. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region. Mol. Cell. Biol. 20:468-477.
25. Nishikawa, K., A. Toker, F. J. Johannes, Z. Songyang, and L. C. Cantley. 1997. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:952-960.
26. Olsen, J. V., et al. 2006. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635-648.
27. Pause, A., et al. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371:762-767.
28. Pyronnet, S., et al. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J. 18:270-279.
29. Raught, B., et al. 2000. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J. 19: 434-444.
30. Roux, P. P., B. A. Ballif, R. Anjum, S. P. Gygi, and J. Blenis. 2004. Tumorpromoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U. S. A. 101:13489-13494.
31. Roux, P. P., et al. 2007. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J. Biol. Chem. 282:14056-14064.
32. Rush, J., et al. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23:94-101.
33. Shahbazian, D., et al. 2006. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25:2781-2791.
34. Shenberger, J. S., et al. 2007. Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation. Int. J. Biochem. Cell Biol. 39:1828-1842.
35. Shveygert, M., C. Kaiser, S. S. Bradrick, and M. Gromeier. 2010. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol. Cell. Biol. 30:5160-5167.
36. Slater, S. J., C. Ho, and C. D. Stubbs. 2002. The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. Chem. Phys. Lipids 116:75-91.
37. Songyang, Z., et al. 1996. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16:6486-6493.
38. Steinberg, S. F. 2008. Structural basis of protein kinase C isoform function. Physiol. Rev. 88:1341-1378.
39. Ubersax, J. A., and J. E. Ferrell, Jr. 2007. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8:530-541.
40. Ueda, T., et al. 2010. Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc. Natl. Acad. Sci. U. S. A. 107:13984-13990.
41. Waskiewicz, A. J., A. Flynn, C. G. Proud, and J. A. Cooper. 1997. Mitogenactivated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1909-1920.
42. Way, K. J., E. Chou, and G. L. King. 2000. Identification of PKC-isoformspecific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21:181-187.
43. Wendel, H. G., et al. 2007. Dissecting eIF4E action in tumorigenesis. Genes Dev. 21:3232-3237.
44. Zhang, H., et al. 2002. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 277:39379-39387.